Highlights
IIA supported (ever)1 patent
About
Oral Mucosa Stem Cell Therapy
Cytora is on a mission to make it standard practice for people to be treated with off-the-shelf (allogeneic) Stem Cell medicines, derived from the readily accessible oral mucosa termed human oral mucosa stem cells - hOMSC, for some of the toughest diseases within this decade, including Parkinson’s, Multiple System Atrophy (MSA), Alzheimer’s Dementia, and non-healing diabetic wounds (IDFU).
Cytora is a portfolio company of Galil Ofek Innovations, a peripheral technology incubator focused primarily on biomedical technologies such as medical devices.
Identity
| Name | Cytora |
|---|---|
| Slug | cytora |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNu45ZQKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ramat Gan |
| HQ address | Arieh Ben Eliezer Street 46, Ramat Gan, Israel |
Web & social
| Website | https://www.cytorastem.com/ |
|---|---|
| https://www.linkedin.com/company/77067876 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
alzheimers-diseasemedical-technologiestherapeuticspharma-companiesdiabetesulcerscell-therapystem-cellsregenerative-medicinebiotechnologyparkinson
Funding
| Total raised | $2.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}